First Republic Investment Management, Inc. P Lx Pharma Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$0.52 - $3.08 $12,045 - $71,348	-23,165 Reduced 43.6%	29,962 $19,000
Q2 2022 Aug 16, 2022	SELL	$1.9 - $4.18 $239,590 - $527,098	-126,100 Reduced 70.36%	53,127 $129,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.3 $369,186 - $865,607	-104,290 Reduced 36.78%	179,227 $724,000
Q4 2021 Feb 09, 2022	BUY	$7.69 - $19.66 $537,238 - $1.37 Million	69,862 Added 32.7%	283,517 $2.27 Million
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $2.37 Million - $4.12 Million	193,655 Added 968.28%	213,655 $4.12 Million
Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $180,000 - $318,800	20,000 New	20,000 $276,000

Others Institutions Holding PLXP

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About PLx Pharma Inc.

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

More about PLXP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account